AGREEMENT
EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Mirum Pharmaceuticals, Inc.
Date: April 14, 2023 | XXXXXXX LIFE SCIENCES IX, L.P. | |||||
By FHMLS IX, L.P., its general partner | ||||||
By FHMLS IX, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLS IX, L.P. | |||||
By FHMLS IX, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLS IX, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | |||||
By: FHMLSP, L.P., its General Partner | ||||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLSP, L.P. | |||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer |
Date: April 14, 2023 | FHMLSP, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P. | |||||
By: FHMLSP Overage, L.P., its General Partner | ||||||
By: FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLSP OVERAGE, L.P. | |||||
By FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLSP OVERAGE, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | XXXXXXX LIFE SCIENCES XI, L.P. | |||||
By FHMLS XI, L.P., its general partner | ||||||
By FHMLS XI, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | FHMLS XI, L.P. | |||||
By FHMLS XI, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer |
Page 2
Date: April 14, 2023 | FHMLS XI, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: April 14, 2023 | By: | /s/ Xxxxx X. Xxxxxx* | ||||
Xxxxx X. Xxxxxx | ||||||
Date: April 14, 2023 | By: | /s/ Xxxxxxx X. Xxxxx* | ||||
Xxxxxxx X. Xxxxx | ||||||
Date: April 14, 2023 | By: | /s/ Xxxxxx Xxx** | ||||
Xxxxxx Xxx | ||||||
Date: April 14, 2023 | By: | /s/ Xxxxx Xxxxx** | ||||
Xxxxx Xxxxx | ||||||
Date: April 14, 2023 | By: | /s/ Xxxxxx Xxxxx*** | ||||
Xxxxxx Xxxxx | ||||||
Date: August 16, 2022 | By: | /s/ Xxxxx X. Xxxxxx | ||||
Xxxxx X. Xxxxxx, as Attorney-in-Fact |
* | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017. |
** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |
*** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022. |
Page 3